Astria Therapeutics (ATXS) PT Raised to $22 at Jefferies
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Price: $12.58 --0%
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Jefferies analyst Eun Yang raised the price target on Astria Therapeutics (NASDAQ: ATXS) to $22.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi raises EquipmentShare price target to $22, keeps Neutral
- Tapestry Inc. (TPR) PT Lowered to $175 at BTIG
- Jefferson Capital (JCAP) PT Raised to $24 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
